Nu Skin Obtains FDA Clearance of Facial Spa Device
FOR IMMEDIATE RELEASE
Investors — Scott Pond (801) 345-2657, firstname.lastname@example.org
Media — Kara Schneck (801) 345-2116, email@example.com
NU SKIN OBTAINS FDA CLEARANCE OF FACIAL SPA DEVICE
PROVO, Utah – Sept. 26, 2013 – Nu Skin Enterprises, Inc. (NYSE: NUS) today announced that it has received FDA clearance to market a facial spa device for over-the-counter cosmetic use. The company’s 510(k) application was filed approximately one year ago. The company estimates that the facial spa will become available for sale some time during the first half of 2014.
“We have seen great demand for our innovative spa products throughout the world which has helped us to become a global leader in the home-use skin care device market,” said Joseph Chang, Ph.D., chief scientific officer. “We are pleased that our U.S. sales leaders and consumers will be able to enjoy the benefits of this skin care device.”
According to a 2012 Kline & Company report, the market for at-home skin care devices has enjoyed double-digit growth globally, with Nu Skin devices leading the way in Asia. The report points to even greater opportunities for growth in the at-home skin care device market in the future.
About Nu Skin Enterprises, Inc.
Nu Skin Enterprises, Inc. demonstrates its tradition of innovation through its comprehensive anti-aging product portfolio, independent business opportunity and corporate social responsibility initiatives. The company’s scientific leadership in both skin care and nutrition has established Nu Skin as a premier anti-aging company. The company’s anti-aging products feature the new ageLOC® suite of products including the ageLOC® R2 nutritional supplement, and ageLOC® Galvanic Body Spa™, as well as the ageLOC® Transformation daily skin care system. A global direct selling company, Nu Skin operates in 53 markets worldwide and is traded on the New York Stock Exchange under the symbol ‘NUS’. More information is available at http://www.nuskin.com.
Please Note: This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended that represent the company's current expectations and beliefs. All statements other than statements of historical fact are “forward-looking statements” for purposes of federal and state securities laws and include, but are not limited to, statements of management's expectations and beliefs regarding the availability for sale of the facial spa in the United States. In some cases, you can identify these statements by forward-looking words such as "believe," "expect," “project,” "anticipate," "estimate," "intend," "plan," "targets," "likely," "will," "would," "could," "may," "might," the negative of these words and other similar words. The forward-looking statements and related assumptions involve risks and uncertainties that could cause actual results and outcomes to differ materially from any forward-looking statements or views expressed herein. These risks and uncertainties include, but are not limited to, the following:(a) any manufacturing issues that delay the availability of the facial spa for marketing and sale in the United States, and (b) any regulatory or other issues that impact the availability and marketing of the facial spa. The forward-looking statements contained herein are further qualified by a detailed discussion of associated risks set forth in the documents filed by the company with the Securities and Exchange Commission. The forward-looking statements set forth the company's beliefs as of the date that such information was first provided and the company assumes no duty to update the forward-looking statements contained in this release to reflect any change except as required by law.